🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial is a phase I/II trial to assess safety, dose finding and feasibi...
Status
Completed
Location
University Hospital of Cologne - Clinic for Internal Medicine I
Start Date
2018-09-25
Trial ID
NCT03664635
Treatments Being Tested
This is an open, single-arm, phase I clinical study to evaluate efficacy an...
Status
Unknown
Location
Hematology Department, Hebei Medical University Fourth Hospital
Start Date
2016-12-26
Trial ID
NCT03121625
Treatments Being Tested
This is a prospective, single-arm, open study to observe the efficacy and s...
Status
Recruiting
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Start Date
2024-10-15
Trial ID
NCT06589089
Treatments Being Tested
The purpose of this study is to determine the efficacy and safety of CD22/C...
Status
Recruiting
Location
Chinese PLA General Hospital, Beijing, Beijing 100853
Start Date
2026-04-01
Trial ID
NCT07779018
Treatments Being Tested
The goal of this clinical study is to compare the study drug KITE-753 versu...
Status
Recruiting
Location
City of Hope Arizona
Start Date
2026-05-22
Trial ID
NCT07479797
Treatments Being Tested
This phase I trial studies the side effects and best dose of genetically mo...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2013-10-08
Trial ID
NCT01815749
The primary purpose of this study is to monitor potential long-term risks a...
Status
Enrolling By Invitation
Location
Colorado Blood Cancer Institute, part of Sarah Cannon Research Institute
Start Date
2025-01-27
Trial ID
NCT06701201
Treatments Being Tested
Alloimmune-mediated platelet transfusion refractoriness(PTR) was usually ca...
Status
Unknown
Location
The First Affiliated Hospital of Soochow University
Start Date
2021-04-29
Trial ID
NCT04846439
Treatments Being Tested
Patients eligible for this study have a type of blood cancer called T-cell ...
Status
Active Not Recruiting
Location
Houston Methodist Hospital
Start Date
2021-08-02
Trial ID
NCT03690011
Treatments Being Tested
The goal of this clinical study is to test how well the study drug, brexuca...
Status
Completed
Location
Banner MD Anderson Cancer Center
Start Date
2021-04-23
Trial ID
NCT04880434
Treatments Being Tested